Sentences with phrase «pharmaceutical companies often»

Also, most pharmaceutical companies often require a grade point average of 2.8 or above to qualify for a pharmaceutical sales interview.

We trust drug manufacturers to produce safe and effective products, but the reality is pharmaceutical companies often come up quite short and choose to put profits ahead of patients.

Big pharmaceutical companies often put stakes in promising start - ups.

Not exact matches

Channel stuffing, which is somewhat common in the pharmaceutical industry, often involves companies incentivizing distributors to buy more than they can likely sell.

Apotex, Canada's largest pharmaceutical company, often has dozens of lawsuits outstanding at a given moment, and the outcomes occasionally have significant impacts on Sherman's personal wealth.

Minutes after Clinton released her statement, White House press secretary Josh Earnest said that «greedy» pharmaceutical companies which jack up costs «often do real damage to their reputation» during a media briefing (while declining to «second guess» Mylan's specific pricing strategies).

And whether the campaign contributions are coming from a pharmaceutical company or a prison guard union, he said, keeping marijuana illegal often boosts donors» bottom lines — and ensures that nonviolent users and suppliers will keep ending up behind bars.

Learn more about how pharmaceutical companies price drugs, why prices are often very high and why it can be difficult to settle on a suitable price.

Drug companies often face the need to come up with new medicines, especially as patents on older pharmaceuticals expire.

They often license promising drugs to bigger pharmaceutical companies, which help pay for development and become responsible for making sales.

Most utilities, packaged food and mature pharmaceutical companies possess characteristics often thought of as typical for value stocks: high free cash generation, high quality balance sheets and high dividend payouts.

«And for pharmaceutical companies, it's often too big of a risk.

Pharmaceuticals and biotechnology companies often have a person responsible for university recruiting.

Often you will hear people talking about why drugs are expensive: it's the greedy pharmaceutical companies, the patent system, the government, capitalism itself.

They are backed by for - profit companies — often pharmaceutical companies — which, like most scientific authors but for different reasons, hope to influence scientific opinion.

Academics often say disdainfully that you need a certain quality to work at a large biotech or pharmaceutical company, and that quality is evil.

In essence, pharmaceutical companies aggressively, and often misleadingly, marketed Ritalin and other stimulants to help fix «troubled» kids.

An MSc in health economics can certainly help, and such courses and fellowships in pharmacoeconomics are often sponsored by pharmaceutical companies.

Activists often slam large pharmaceutical companies for failing to develop drugs that are of critical importance to the developing world.Andrew Witty, GlaxoSmithKline's youthful chief executive, gave those critics pause yesterday in a speech to the Council on Foreign Relations in New York City.Witty promised to sell the company's malaria vaccine that is in late - stage clinical trials in Africa for no more than a 5 percent profit.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs.

Medicinal chemists often find their way into pharmaceutical companies, but Buolamwini likes the freedom of academia, and the ability to contribute innovative ideas as well as the chance to train young scientists.

In the past, when we've talked to various pharmaceutical companies about one program or another in our lab, they often want to wait until it's been developed into a preliminary screen, and would rather work with biotech companies for collaborations — they've often been the intermediate window before a pharmaceutical company would step in.

This is not unlike the pharmaceutical companies that appear to sit around dreaming up new ailments that their miracle drugs might cure — ailments that people often didn't even know they had until they learned about them on TV or the internet.

Often, realtors own rental real estate, Silicon Valley employees dabble in technology stocks and doctors buy shares in pharmaceutical companies.

Which has its pros & cons: Investors mostly adjust accordingly (i.e. reverse out some / all of this intangible expense), which explains why intellectual property companies (as in technology, media, pharmaceuticals, etc.) often trade on steep earnings multiples vs. the rest of the market.

These are fun parasitology facts that every veterinary student memorized in school, and that in my opinion, are often glassed over by pharmaceutical companies whose goal is to sell more preventative pills each month.

We know that what pharmaceutical companies, doctors, dog food companies and, yes, vets say is often biased by what's in it for them.

And the company has been working with BBA to clean up the supply chain of mica, a mineral that is often mined using exploited child labor for the gain of large electronics, pharmaceutical, and cosmetics companies.

For decades, companies developing pharmaceuticals, cosmetics, or agricultural seed profited from the biodiversity and traditional knowledge of other nations, often doing little to share those revenues.

• Novartis Investments S.A.R.L., a subsidiary of the Novartis pharmaceutical company that often seeks regulatory approval for its drugs.

Though many doubted that large institutions like law firms are capable of change, one participant, Professor John Coates (formerly of Wachtell, which he left because he felt that the firm's structure and clients stymied true innovation) offered the idea that law firms might follow the example of big pharmaceutical companies that have created innovative research subsidiaries, often teaming with startup companies.

For this reason, lawsuits against pharmaceutical companies are often handled in a type of lawsuit called a «mass tort».

Over the past 10 years the Competition Bureau has only initiated similar formal «document / information requests» to less than 10 other brand pharmaceutical companies (often relating to mergers, price fixing, and often resulting in consent judgements or agreements).

The pharmaceutical sales field, often called «recession - proof,» is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of a company car.